Literature DB >> 29296945

The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages.

Fabian C Verbij1, Nicoletta Sorvillo1, Paul H P Kaijen1, Johana Hrdinova1, Ivan Peyron1, Rob Fijnheer2, Anja Ten Brinke3, Alexander B Meijer1,4, Floris P J van Alphen1, Timo K van den Berg5, Jonas J H Graversen6, Soren K Moestrup6, Jan Voorberg1,7,8.   

Abstract

Internalization of ADAMTS13 by macrophages may contribute to its clearance from the circulation. Here we investigated endocytic mechanisms that contribute to the uptake of ADAMTS13 by macrophages. Human monocyte-derived macrophages were used to monitor the uptake of fluorescently labeled recombinant ADAMTS13 by flow cytometry. Internalization of ADAMTS13 was blocked upon addition of the cell-permeable dynamin inhibitor dynasore. Partial blocking of ADAMTS13 uptake was observed by using mannan; however, uptake was not affected by an antibody that blocked binding to the macrophage mannose receptor CD206, which suggests that other endocytic receptors contribute to the internalization of ADAMTS13 by macrophages. A pull-down with ADAMTS13 and subsequent mass spectrometric analysis identified the class I scavenger receptor CD163 as a candidate receptor for ADAMTS13. Blocking experiments with monoclonal anti-CD163 antibody EDHu-1 resulted in decreased ADAMTS13 internalization by macrophages. Pronounced inhibition of ADAMTS13 uptake by EDHu-1 was observed in CD163 high-expressing macrophages. In agreement with these findings, CD163-expressing Chinese hamster ovary cells were capable of rapidly internalizing ADAMTS13. Surface plasmon resonance revealed binding of ADAMTS13 to scavenger receptor cysteine-rich domains 1-9 and 1-5 of CD163. Taken together, our data identify CD163 as a major endocytic receptor for ADAMTS13 on macrophages.

Entities:  

Year:  2017        PMID: 29296945      PMCID: PMC5744037          DOI: 10.1182/bloodadvances.2016001321

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  55 in total

Review 1.  CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma.

Authors:  Jonas Heilskov Graversen; Mette Madsen; Søren K Moestrup
Journal:  Int J Biochem Cell Biol       Date:  2002-04       Impact factor: 5.085

2.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

3.  Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis.

Authors:  Tom Kirchhausen; Eric Macia; Henry E Pelish
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

Review 4.  The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis.

Authors:  Vanesa Gabriela Martínez; Søren Kragh Moestrup; Uffe Holmskov; Jan Mollenhauer; Francisco Lozano
Journal:  Pharmacol Rev       Date:  2011-08-31       Impact factor: 25.468

5.  The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura.

Authors:  Marie-Luise John; Walter Hitzler; Inge Scharrer
Journal:  Ann Hematol       Date:  2011-12-28       Impact factor: 3.673

6.  ADAMTS13 is expressed in hepatic stellate cells.

Authors:  Wenhua Zhou; Mari Inada; Tai-Ping Lee; Daniel Benten; Sergey Lyubsky; Eric E Bouhassira; Sanjeev Gupta; Han-Mou Tsai
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

7.  Role of Kupffer cells in pathogenesis of sepsis-induced drug metabolizing dysfunction.

Authors:  Tae-Hoon Kim; Sang-Ho Lee; Sun-Mee Lee
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

8.  IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  S Ferrari; G C Mudde; M Rieger; A Veyradier; J A Kremer Hovinga; F Scheiflinger
Journal:  J Thromb Haemost       Date:  2009-08-11       Impact factor: 5.824

9.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

10.  ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.

Authors:  Manfred Rieger; Pier Mannuccio Mannucci; Johanna A Kremer Hovinga; Andrea Herzog; Gabi Gerstenbauer; Christian Konetschny; Klaus Zimmermann; Inge Scharrer; Flora Peyvandi; Miriam Galbusera; Giuseppe Remuzzi; Martina Böhm; Barbara Plaimauer; Bernhard Lämmle; Friedrich Scheiflinger
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

View more
  4 in total

1.  Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.

Authors:  Johana Hrdinová; Fabian C Verbij; Paul H P Kaijen; Robin B Hartholt; Floris van Alphen; Neubury Lardy; Anja Ten Brinke; Karen Vanhoorelbeke; Pooja J Hindocha; Anne S De Groot; Alexander B Meijer; Jan Voorberg; Ivan Peyron
Journal:  Haematologica       Date:  2018-03-22       Impact factor: 9.941

Review 2.  Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.

Authors:  Aicha Laghmouchi; Nuno A G Graça; Jan Voorberg
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

3.  Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease.

Authors:  Sara Konstantin Nissen; Sara Almeida Ferreira; Marlene Christina Nielsen; Claudia Schulte; Kalpana Shrivastava; Dorle Hennig; Anders Etzerodt; Jonas Heilskov Graversen; Daniela Berg; Walter Maetzler; Anne Panhelainen; Holger Jon Møller; Kathrin Brockmann; Marina Romero-Ramos
Journal:  Mov Disord       Date:  2020-12-17       Impact factor: 10.338

4.  Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis.

Authors:  Sandrine Valade; Bérangère S Joly; Agnès Veyradier; Jehane Fadlallah; Lara Zafrani; Virginie Lemiale; Amélie Launois; Alain Stepanian; Lionel Galicier; Claire Fieschi; Adrien Mirouse; Jean Jacques Tudesq; Anne-Claire Lepretre; Elie Azoulay; Michael Darmon; Eric Mariotte
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.